About: PRC200-SS

An Entity of Type: chemical substance, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

PRC200-SS is an experimental drug of the triple reuptake inhibitor class that was investigated by the Mayo Clinic. Preclinical toxicology studies of PRC200-SS in cynomolgus monkeys showed dose proportional kidney toxicity, precluding any further drug development.

Property	Value
dbo:abstract	PRC200-SS is an experimental drug of the triple reuptake inhibitor class that was investigated by the Mayo Clinic. Preclinical toxicology studies of PRC200-SS in cynomolgus monkeys showed dose proportional kidney toxicity, precluding any further drug development. (en)
dbo:casNumber	492434-58-9
dbo:pubchem	20631904
dbo:thumbnail	wiki-commons:Special:FilePath/PRC200_structure.png?width=300
dbo:wikiPageID	23928336 (xsd:integer)
dbo:wikiPageLength	3052 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID	1120772415 (xsd:integer)
dbo:wikiPageWikiLink	dbc:Abandoned_drugs dbc:Amines dbc:Secondary_alcohols dbr:Mayo_Clinic dbr:Drug_development dbc:2-Naphthyl_compounds dbc:Serotonin–norepinephrine–dopamine_reuptake_inhibitors dbr:Crab-eating_macaque dbr:Preclinical dbr:Triple_reuptake_inhibitor
dbp:c	20 (xsd:integer)
dbp:casNumber	492434 (xsd:integer)
dbp:chemspiderid	19318181 (xsd:integer)
dbp:h	21 (xsd:integer)
dbp:iupacName	-3 (xsd:integer)
dbp:n	1 (xsd:integer)
dbp:o	1 (xsd:integer)
dbp:pubchem	20631904 (xsd:integer)
dbp:smiles	O[C@H][C@H]c2cc3ccccc3cc2 (en)
dbp:stdinchi	1 (xsd:integer)
dbp:stdinchikey	RSZGIFQDUIROGN-WOJBJXKFSA-N (en)
dbp:verifiedfields	changed (en)
dbp:verifiedrevid	451223794 (xsd:integer)
dbp:watchedfields	changed (en)
dbp:wikiPageUsesTemplate	dbt:Drugbox dbt:Reflist dbt:Short_description dbt:Cascite dbt:Chemspidercite dbt:Stdinchicite dbt:Antidepressants dbt:Monoamine_reuptake_inhibitors
dcterms:subject	dbc:Abandoned_drugs dbc:Amines dbc:Secondary_alcohols dbc:2-Naphthyl_compounds dbc:Serotonin–norepinephrine–dopamine_reuptake_inhibitors
rdf:type	owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 dbo:Drug
rdfs:comment	PRC200-SS is an experimental drug of the triple reuptake inhibitor class that was investigated by the Mayo Clinic. Preclinical toxicology studies of PRC200-SS in cynomolgus monkeys showed dose proportional kidney toxicity, precluding any further drug development. (en)
rdfs:label	PRC200-SS (en)
owl:sameAs	wikidata:PRC200-SS dbpedia-sh:PRC200-SS dbpedia-sr:PRC200-SS https://global.dbpedia.org/id/4ssBH
prov:wasDerivedFrom	wikipedia-en:PRC200-SS?oldid=1120772415&ns=0
foaf:depiction	wiki-commons:Special:FilePath/PRC200_structure.png
foaf:isPrimaryTopicOf	wikipedia-en:PRC200-SS
is dbo:wikiPageRedirects of	dbr:PRC200 dbr:PRC050
is dbo:wikiPageWikiLink of	dbr:List_of_adrenergic_drugs dbr:Arylalkanolamine dbr:C20H21NO dbr:Serotonin–norepinephrine–dopamine_reuptake_inhibitor dbr:PRC200 dbr:Monoamine_transporter dbr:PRC050
is foaf:primaryTopic of	wikipedia-en:PRC200-SS